Gastric Desmoid Tumor: An Infrequent Case of Intra-Abdominal Fibromatosis

  1. Macias N 1
  2. Abdel-lah O 1
  3. Parreño FC 1
  4. Blanco O 1
  5. Bengoechea O 1
  6. Martínez SC 1
  1. 1 Hospital Universitario de Salamanca

    Hospital Universitario de Salamanca

    Salamanca, España


Journal of Gastrointestinal & Digestive System

ISSN: 2161-069X

Year of publication: 2015

Volume: 05

Issue: 05

Type: Article

DOI: 10.4172/2161-069X.1000332 GOOGLE SCHOLAR

More publications in: Journal of Gastrointestinal & Digestive System

Sustainable development goals


Background and purpose: Desmoid tumors or aggressive fibromatosis are infrequent conditions, with a large clinical variability, and preferencial location on abdominal wall, extra-abdominal soft tissue, and mesentery. Histologically benign but locally aggressive, they have a marked tendency to recurrence. There are two known variants: sporadic and associated to familial adenomatous polyposis. Its etiology remains unknown, but it appears to be related to estrogenic estimulation, surgical aggression and mutations of the short arm of chromosome 5. Diagnosis is usually difficult, and must combine medical history, semiology and imaging, though only histological analysis of the specimen will provide a definitive diagnosis after surgical resection, which is potentially curative. Gastric location has not been reported so far. Case report: 37-year-old woman with recent delivery, presenting abdominal lump with non specific clinical semiology and rapid growth rate. After diagnostic tests, a hypervascular mass of about 15 centimeter of diameter, depending on gastric wall is found. She underwent an elective distal gastrectomy and Billroth I reconstruction. Histology confirms a mesenchymal desmoid gastric tumor. Discussion: The differential diagnosis for abdominal oligosymptomatic lumps which respect the mucosa of the gastrointestinal tract lead clinical suspicion to mesenchymal tumors such as sarcomas, desmoids, or GIST. Radiologic tests are useful to confirm resectability and detect complications. When facing unresectable disease, planning a biopsy and systemic treatment with chemotherapy and/or radical radiotherapy should be considered. Diagnosis is reached after histological and inmunohistochemical analysis of the specimen, which in case of a desmoid, will show negative expression to markers of sarcoma (actin, desmin, S100) or GIST (CD117, DOG1, PDGFRA), and positive staining with anti-beta-catenin. Conclusion: Desmoid tumors should be considered in the differential diagnosis of abdominal oligosymptomatic masses, specially in fertile women or if history of surgical trauma. Patients with desmoid tumors should undergo colonic polyposis screening, as well as patients with adenomatous polyposis and an abdominal lump should lead suspected diagnosis to the possibility of a desmoid tumor.

Bibliographic References

  • Shields CJ, Winter DC, Kirwan WO, Redmond HP (2001) Desmoid tumours. Eur J SurgOncol 27: 701-706.
  • Sutton RJ, Thomas JM (1999)Desmoid tumours of the anterior abdominal wall. Eur J SurgOncol 25:398-400.
  • Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF (1999) The enigma of desmoidtumors. Ann Surg 229: 866-872.
  • Kulaylat MN, Karakousis CP, Keaney CM, McCorvey D, Bem J, et al. (1999) Desmoid tumour: a pleomorphic lesion. Eur J SurgOncol 25: 487-497.
  • Dalén BP, Bergh PM, Gunterberg BU (2003) Desmoidtumors: a clinical review of 30 patients with more than 20 years' follow-up. ActaOrthopScand 74: 455-459.
  • Mendenhall WM, Zlotecki RA, Morris CG, Hochwald SN, Scarborough MT (2005) Aggressive fibromatosis. Am J ClinOncol 28: 211-215.
  • Phillips SR, A'Hern R, Thomas JM (2004) Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. Br J Surg 91: 1624-1629.
  • Gurbuz AK, Giardiello FM, Petersen GM, Krush AJ, Offerhaus GJ, et al. (1994) Desmoid tumours in familial adenomatous polyposis. Gut 35: 377-381.
  • Vasen HF, Möslein G, Alonso A, Bernstein I, Bertario L, et al. (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44: 353-362.
  • Ishizuka M, Hatori M, Dohi O, Suzuki T, Miki Y, et al. (2006) Expression profiles of sex steroid receptors in desmoidtumors. Tohoku J Exp Med 210: 189-198.
  • Okuno S (2006) The enigma of desmoidtumors. Curr Treat Options Oncol 7: 438-443.